220 related articles for article (PubMed ID: 12595639)
1. Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A.
Kobayashi I; Yamada M; Takahashi Y; Kawamura N; Okano M; Sakiyama Y; Kobayashi K
Rheumatology (Oxford); 2003 Feb; 42(2):371-4. PubMed ID: 12595639
[TBL] [Abstract][Full Text] [Related]
2. Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease.
Go DJ; Park JK; Kang EH; Kwon HM; Lee YJ; Song YW; Lee EB
Rheumatol Int; 2016 Jan; 36(1):125-31. PubMed ID: 26223808
[TBL] [Abstract][Full Text] [Related]
3. Clinical analysis and outcome of interstitial lung disease complicated with juvenile dermatomyositis and juvenile polymyositis.
Sato S; Uejima Y; Nanbu M; Suganuma E; Takano T; Tanaka R; Kabuki T; Oguma E; Oh-Ishi T; Kawano Y
Mod Rheumatol; 2017 Jul; 27(4):652-656. PubMed ID: 27588444
[TBL] [Abstract][Full Text] [Related]
4. [Clinical characteristics of juvenile dermatomyositis complicated with interstitial lung disease].
Chen L; Hu Y; Yao Y; Zhen XF; Chen F; He Q; Mo X; Ma SC
Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):465-9. PubMed ID: 22931947
[TBL] [Abstract][Full Text] [Related]
5. Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report.
Quintana-Ortega C; Remesal A; Ruiz de Valbuena M; de la Serna O; Laplaza-González M; Álvarez-Rojas E; Udaondo C; Alcobendas R; Murias S
Mod Rheumatol Case Rep; 2021 Jan; 5(1):101-107. PubMed ID: 33019894
[TBL] [Abstract][Full Text] [Related]
6. Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review.
Nishi K; Ogura M; Tamai N; Gima M; Ide K; Koinuma G; Kamei K; Ito S
Pediatr Rheumatol Online J; 2022 Aug; 20(1):60. PubMed ID: 35927666
[TBL] [Abstract][Full Text] [Related]
7. Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis.
Kobayashi N; Takezaki S; Kobayashi I; Iwata N; Mori M; Nagai K; Nakano N; Miyoshi M; Kinjo N; Murata T; Masunaga K; Umebayashi H; Imagawa T; Agematsu K; Sato S; Kuwana M; Yamada M; Takei S; Yokota S; Koike K; Ariga T
Rheumatology (Oxford); 2015 May; 54(5):784-91. PubMed ID: 25288783
[TBL] [Abstract][Full Text] [Related]
8. [A case of corticosteroid-resistant nonspecific interstitial pneumonia associated with dermatomyositis successfully treated with cyclosporin A].
Sakamoto S; Homma S; Kawabat M; Kono T; Motoi N; Yoshimur K
Nihon Kokyuki Gakkai Zasshi; 2005 Mar; 43(3):171-8. PubMed ID: 15801287
[TBL] [Abstract][Full Text] [Related]
9. [Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review].
Hou J; Zhou ZX; Li JG; Xu YJ; Ding YC
Zhonghua Er Ke Za Zhi; 2019 Dec; 57(12):928-933. PubMed ID: 31795559
[No Abstract] [Full Text] [Related]
10. Respiratory symptoms as initial manifestations of interstitial lung disease in clinically amyopathic juvenile dermatomyositis: a case report with literature review.
Xia J; Jiang G; Jin T; Shen Q; Ma Y; Wang L; Qian L
BMC Pediatr; 2021 Nov; 21(1):488. PubMed ID: 34732158
[TBL] [Abstract][Full Text] [Related]
11. Lung infection or inflammation-a puzzling case of MDA-5 associated juvenile dermatomyositis.
Vuppala A; Sondhi M; Umer S
Pediatr Rheumatol Online J; 2023 Dec; 21(1):147. PubMed ID: 38124190
[TBL] [Abstract][Full Text] [Related]
12. Increased Serum B Cell Activating Factor and a Proliferation-inducing Ligand Are Associated with Interstitial Lung Disease in Patients with Juvenile Dermatomyositis.
Kobayashi N; Kobayashi I; Mori M; Sato S; Iwata N; Shigemura T; Agematsu K; Yokota S; Koike K
J Rheumatol; 2015 Dec; 42(12):2412-8. PubMed ID: 26472413
[TBL] [Abstract][Full Text] [Related]
13. Early intervention with corticosteroids and cyclosporin A and 2-hour postdose blood concentration monitoring improves the prognosis of acute/subacute interstitial pneumonia in dermatomyositis.
Kotani T; Makino S; Takeuchi T; Kagitani M; Shoda T; Hata A; Tabushi Y; Hanafusa T
J Rheumatol; 2008 Feb; 35(2):254-9. PubMed ID: 18085732
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of probenecid for a patient with juvenile dermatomyositis complicated with calcinosis.
Nakamura H; Kawakami A; Ida H; Ejima E; Origuchi T; Eguchi K
J Rheumatol; 2006 Aug; 33(8):1691-3. PubMed ID: 16881125
[TBL] [Abstract][Full Text] [Related]
15. Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report.
Kishi T; Tani Y; Okiyama N; Mizuochi K; Ichimura Y; Harigai M; Nagata S; Miyamae T
Pediatr Rheumatol Online J; 2021 Mar; 19(1):34. PubMed ID: 33740993
[TBL] [Abstract][Full Text] [Related]
16. [Nation-wide survey for the treatment with cyclosporin A of interstitial pneumonia associated with collagen diseases].
Harigai M; Hara M; Kamatani N; Kashiwazaki S
Ryumachi; 1999 Dec; 39(6):819-28. PubMed ID: 10695405
[TBL] [Abstract][Full Text] [Related]
17. Juvenile dermatomyositis: clinical characteristics and the relatively high risk of interstitial lung disease.
Morinishi Y; Oh-Ishi T; Kabuki T; Joh K
Mod Rheumatol; 2007; 17(5):413-7. PubMed ID: 17929135
[TBL] [Abstract][Full Text] [Related]
18. Anti-melanoma differentiation-associated gene 5 antibody is a diagnostic and predictive marker for interstitial lung diseases associated with juvenile dermatomyositis.
Kobayashi I; Okura Y; Yamada M; Kawamura N; Kuwana M; Ariga T
J Pediatr; 2011 Apr; 158(4):675-7. PubMed ID: 21232756
[TBL] [Abstract][Full Text] [Related]
19. The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease.
Sugiyama Y; Yoshimi R; Tamura M; Takeno M; Kunishita Y; Kishimoto D; Yoshioka Y; Kobayashi K; Takase-Minegishi K; Watanabe T; Hamada N; Nagai H; Tsuchida N; Soejima Y; Nakano H; Kamiyama R; Uehara T; Kirino Y; Sekiguchi A; Ihata A; Ohno S; Nagaoka S; Nakajima H
Arthritis Res Ther; 2018 Jan; 20(1):7. PubMed ID: 29325580
[TBL] [Abstract][Full Text] [Related]
20. Combination with corticosteroids and cyclosporin-A improves pulmonary function test results and chest HRCT findings in dermatomyositis patients with acute/subacute interstitial pneumonia.
Kotani T; Takeuchi T; Makino S; Hata K; Yoshida S; Nagai K; Wakura D; Shoda T; Hanafusa T
Clin Rheumatol; 2011 Aug; 30(8):1021-8. PubMed ID: 21340495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
